180 related articles for article (PubMed ID: 15450775)
21. Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis.
Garbern JY
Cell Mol Life Sci; 2007 Jan; 64(1):50-65. PubMed ID: 17115121
[TBL] [Abstract][Full Text] [Related]
22. Further evidence for a fourth gene causing X-linked pure spastic paraplegia.
Starling A; Rocco P; Cambi F; Hobson GM; Passos Bueno MR; Zatz M
Am J Med Genet; 2002 Aug; 111(2):152-6. PubMed ID: 12210342
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathways of oligodendrocyte apoptosis revealed by mutations in the proteolipid protein gene.
Southwood C; Gow A
Microsc Res Tech; 2001 Mar; 52(6):700-8. PubMed ID: 11276122
[TBL] [Abstract][Full Text] [Related]
24. Peripheral neuropathy caused by proteolipid protein gene mutations.
Garbern JY; Cambi F; Lewis R; Shy M; Sima A; Kraft G; Vallat JM; Bosch EP; Hodes ME; Dlouhy S; Raskind W; Bird T; Macklin W; Kamholz J
Ann N Y Acad Sci; 1999 Sep; 883():351-65. PubMed ID: 10586260
[TBL] [Abstract][Full Text] [Related]
25. A PLP splicing abnormality is associated with an unusual presentation of PMD.
Hobson GM; Huang Z; Sperle K; Stabley DL; Marks HG; Cambi F
Ann Neurol; 2002 Oct; 52(4):477-88. PubMed ID: 12325077
[TBL] [Abstract][Full Text] [Related]
26. Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease.
Hobson GM; Davis AP; Stowell NC; Kolodny EH; Sistermans EA; de Coo IF; Funanage VL; Marks HG
Neurology; 2000 Oct; 55(8):1089-96. PubMed ID: 11071483
[TBL] [Abstract][Full Text] [Related]
27. Position effect on PLP1 may cause a subset of Pelizaeus-Merzbacher disease symptoms.
Muncke N; Wogatzky BS; Breuning M; Sistermans EA; Endris V; Ross M; Vetrie D; Catsman-Berrevoets CE; Rappold G
J Med Genet; 2004 Dec; 41(12):e121. PubMed ID: 15591263
[No Abstract] [Full Text] [Related]
28. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
Laukka JJ; Kamholz J; Bessert D; Skoff RP
Neurosci Lett; 2016 Aug; 627():222-32. PubMed ID: 27222925
[TBL] [Abstract][Full Text] [Related]
29. CNS myelination and PLP gene dosage.
Woodward K; Malcolm S
Pharmacogenomics; 2001 Aug; 2(3):263-72. PubMed ID: 11535114
[TBL] [Abstract][Full Text] [Related]
30. Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations.
Inoue K; Osaka H; Imaizumi K; Nezu A; Takanashi J; Arii J; Murayama K; Ono J; Kikawa Y; Mito T; Shaffer LG; Lupski JR
Ann Neurol; 1999 May; 45(5):624-32. PubMed ID: 10319885
[TBL] [Abstract][Full Text] [Related]
31. Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease.
Pizzini F; Fatemi AS; Barker PB; Nagae-Poetscher LM; Horská A; Zimmerman AW; Moser HW; Bibat G; Naidu S
AJNR Am J Neuroradiol; 2003 Sep; 24(8):1683-9. PubMed ID: 13679292
[TBL] [Abstract][Full Text] [Related]
32. Unusual clinical and magnetic resonance imaging findings in a family with proteolipid protein gene mutation.
Battini R; Bianchi MC; Boespflug-Tanguy O; Tosetti M; Bonanni P; Canapicchi R; Cioni G
Arch Neurol; 2003 Feb; 60(2):268-72. PubMed ID: 12580714
[TBL] [Abstract][Full Text] [Related]
33. [Early diagnosis of a serious form of Pelizaeus-Merzbacher's disease confirmed by molecular analysis of the gene for proto-lipoproteins].
López-Pisón J; Muñoz-Albillos M; Moros-Peña M; Medrano-Marina P; Ruiz-Escusol S; Boespflug-Tanguy O
Rev Neurol; 1999 Sep 1-15; 29(5):429-32. PubMed ID: 10584245
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease.
Carango P; Funanage VL; Quirós RE; Debruyn CS; Marks HG
Ann Neurol; 1995 Oct; 38(4):610-7. PubMed ID: 7574457
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of Pelizaeus-Merzbacher disease: detection of proteolipid protein gene copy number by real-time PCR.
Regis S; Grossi S; Lualdi S; Biancheri R; Filocamo M
Neurogenetics; 2005 May; 6(2):73-8. PubMed ID: 15827763
[TBL] [Abstract][Full Text] [Related]
36. X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations.
Woodward K; Kirtland K; Dlouhy S; Raskind W; Bird T; Malcolm S; Abeliovich D
Eur J Hum Genet; 2000 Jun; 8(6):449-54. PubMed ID: 10878666
[TBL] [Abstract][Full Text] [Related]
37. Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia.
Cambi F; Tang XM; Cordray P; Fain PR; Keppen LD; Barker DF
Neurology; 1996 Apr; 46(4):1112-7. PubMed ID: 8780101
[TBL] [Abstract][Full Text] [Related]
38. Myelination of a fetus with Pelizaeus-Merzbacher disease: immunopathological study.
Shiraishi K; Itoh M; Sano K; Takashima S; Kubota T
Ann Neurol; 2003 Aug; 54(2):259-62. PubMed ID: 12891682
[TBL] [Abstract][Full Text] [Related]
39. Novel
Margraf RL; Durtschi J; Krock B; Newcomb TM; Bonkowsky JL; Voelkerding KV; Bayrak-Toydemir P; Lutz RE; Swoboda KJ
Child Neurol Open; 2018; 5():2329048X18789282. PubMed ID: 30046645
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
